[1]
“A Stability Indicating RP-HPLC Method Validation for simultaneous estimation of Azelnidipine and Telmisartan in a fixed-dose combination”, Int. J. Pharm. Sci. Drug Res., vol. 13, no. 3, pp. 288–294, May 2021, doi: 10.25004/IJPSDR.2021.130308.